Inhibition of Platelet Aggregation with a Glycoprotein IIb-IIIa Antagonist Does Not Prevent Thrombin Generation in Patients Undergoing Thrombolysis for Acute Myocardial Infarction
Preface
Community Impact of Anticoagulation Services
Anticoagulation Clinics and Patient Self-Testing for Patients on Chronic Warfarin Therapy
Homocysteine and Risk of Cardiovascular Disease
Low Molecular Weight Heparin in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism
Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists
Heparin-Induced Thrombocytopenia and its Treatment
Ticlopidine Enhances the Platelet Inhibitory Capacity of Abciximab In Vitro
Medicare Coverage Policies
Effect of Short-Term Aspirin Use on C-Reactive Protein
INR Self-Management Following Mechanical Heart Valve Replacement
Incidence of Factor V Leiden in Patients with Acute Myocardial Infarction
Anticoagulation Therapy for Atrial Fibrillation and Coronary Disease
Prevention of Left Ventricular Remodeling by Percutaneous Transluminal Coronary Angioplasty Performed 24 Hours After the Onset of Acute Myocardial Infarction
Workshop
Soluble E-Selectin is Not a Marker of Unstable Coronary Plaque in Serum of Patients with Ischemic Heart Disease
Workshop
Workshop
Workshop
Key References
Abstracts
Key References
Key References
Key References
Key References on a Wide Variety of Topics Pertaining to Coronary Artery Blood Flow and Patency
Reference Guide to Cardiogenic Shock Complicating Acute Myocardial Infarction
Ischemic Preconditioning
Pathology/Physiology Including Thrombosis
Role of ACE Inhibition in Acute Coronary Syndromes
Venous Thromboembolism in the Elderly
Key References
Key References
Update in Unfractionated Heparin, Low-Molecular-Weight Heparins, and Heparinoids in the Elderly (Age ≤ 65 years)
Key References
Key References
Key References
Key References
Key References
Key References